Abstract: An electric motor is provided including a rotor and an outer member that is coaxially placed around the inner member and having radially oriented teeth. The teeth have end parts with a width Wt, adjacent teeth being separated by a slot of slot width Wg. A number of barrier members are provided in the inner member near the inner perimeter, each barrier member having a width Wb that generally corresponds to the width Wt and having curved side sections at each end of the central section having a width that generally corresponds with the slot width Wg. The barrier members reduce electromagnetic NVH by preventing magnetic flux from passing from the slots on each side of the teeth, into the inner member.

Abstract: A method of treating a medical condition with a combination of substances, wherein one of the substances is adalimumab, in combination with a computer program configured for: providing a patient with sets of questions adapted to the combination, to adalimumab, and to the non-adalimumab substances, wherein at least one of the sets of questions is related to perceived and/or measured therapeutic effects; subjecting the answers to the sets of questions to functions, thereby generating patient specific feedback; and adjusting a dosage of at least one substance based at least in part on the patient-specific feedback.

Abstract: A method of treating a respiratory disorder with a combination of substances in combination with a computer program configured for: providing a patient with sets of questions adapted to the combination and to the substances in the combination; subjecting the answers to the sets of questions to functions, thereby generating patient specific feedback; and providing the feedback to the patient.

Abstract: A method of treating a medical condition with a combination of substances, wherein one of the substances is adalimumab, in combination with a computer program configured for: providing a patient with sets of questions adapted to the combination, to adalimumab, and to the non-adalimumab substances, wherein the sets of questions serve to identify potential side effects; subjecting the answers to the sets of questions to functions, thereby generating patient specific feedback; providing the feedback to the patient, wherein the feedback is directed to making the patient aware of development of a possible side effect.

Abstract: A combination of N>1 substances with pharmaceutical activity against at least one medical condition for treating the medical condition with a program including instructions causing a computer to perform a method including: providing a patient with a set of questions adapted to the combination according to a question schedule; providing a patient with N sets of questions according to N question schedules, wherein each set of questions is adapted to one substance; collecting answers to the sets of questions from the patient; subjecting the answers to the set of questions adapted to the combination to a set of functions, thereby generating a first patient feedback; subjecting the answers to the sets of questions each adapted for one substance, to N sets of functions, thereby generating a second patient specific feedback; and providing the first and second specific feedbacks to the patient.

Abstract: The present invention relates to a substance with pharmaceutical activity against a medical condition for use in a treatment of said medical condition in combination with a computer program product comprising instructions causing a computer to perform a method comprising the steps —providing a patient with a set of questions according to a question schedule, wherein said set of questions is specific to the pharmaceutical product; —collecting answers to said questions from said patient; —subjecting said answers to a set of functions specific for the set of questions and the pharmaceutical product thereby generating patient specific feedback information; —providing said feedback information to the patient; and optionally extracting clinically relevant information from said answers and providing said clinically relevant information to a database adapted for collecting clinically relevant information during clinical use of said substance.

Abstract: The present invention relates to a substance with pharmaceutical activity against a medical condition for use in a treatment of said medical condition in combination with a computer program product comprising instructions causing a computer to perform a method comprising the steps providing a patient with a set of questions according to a question schedule, wherein said set of questions is specific to the pharmaceutical product; collecting answers to said questions from said patient; subjecting said answers to a set of functions specific for the set of questions and the pharmaceutical product thereby generating patient specific feedback information; providing said feedback information to the patient; and optionally extracting clinically relevant information from said answers and providing said clinically relevant information to a database adapted for collecting clinically relevant information during clinical use of said substance.

Abstract: A combination of N>1 substances with pharmaceutical activity against at least one medical condition for treating the medical condition with a program including instructions causing a computer to perform a method including: providing a patient with a set of questions adapted to the combination according to a question schedule; providing a patient with N sets of questions according to N question schedules, wherein each set of questions is adapted to one substance; collecting answers to the sets of questions from the patient; subjecting the answers to the set of questions adapted to the combination to a set of functions, thereby generating a first patient feedback; subjecting the answers to the sets of questions each adapted for one substance, to N sets of functions, thereby generating a second patient specific feedback; and providing the first and second specific feedbacks to the patient.

Abstract: The present invention relates to a substance with pharmaceutical activity against a medical condition for use in a treatment of said medical condition in combination with a computer program product comprising instructions causing a computer to perform a method comprising the steps—providing a patient with a set of questions according to a question schedule, wherein said set of questions is specific to the pharmaceutical product;—collecting answers to said questions from said patient;—subjecting said answers to a set of functions specific for the set of questions and the pharmaceutical product thereby generating patient specific feedback information;—providing said feedback information to the patient; and optionally extracting clinically relevant information from said answers and providing said clinically relevant information to a database adapted for collecting clinically relevant information during clinical use of said substance.

Abstract: The present invention relates to a substance with pharmaceutical activity against a medical condition for use in a treatment of said medical condition in combination with a computer program product comprising instructions causing a computer to perform a method comprising the steps providing a patient with a set of questions according to a question schedule, wherein said set of questions is specific to the pharmaceutical product; collecting answers to said questions from said patient; subjecting said answers to a set of functions specific for the set of questions and the pharmaceutical product thereby generating patient specific feedback information; providing said feedback information to the patient; and optionally extracting clinically relevant information from said answers and providing said clinically relevant information to a database adapted for collecting clinically relevant information during clinical use of said substance.

Abstract: A substance with pharmaceutical activity against a medical condition for use in a treatment of the medical condition in combination with a computer program product including instructions causing a computer to perform a method including: providing a patient with a set of questions according to a question schedule, wherein the set of questions is adapted to the pharmaceutical product; collecting answers to the questions from the patient; subjecting the answers to a set of functions adapted for the set of questions and the pharmaceutical product thereby generating patient-specific feedback information; providing the feedback information to the patient; and extracting information from the answers and providing the information to a database adapted to collect information during clinical use of the substance, and store a multitude of relevant information.

Abstract: A combination of N>1 substances with pharmaceutical activity against at least one medical condition for treating the medical condition with a program including instructions causing a computer to perform a method including: providing a patient with a set of questions adapted to the combination according to a question schedule; providing a patient with N sets of questions according to N question schedules, wherein each set of questions is adapted to one substance; collecting answers to the sets of questions from the patient; subjecting the answers to the set of questions adapted to the combination to a set of functions, thereby generating a first patient feedback; subjecting the answers to the sets of questions each adapted for one substance, to N sets of functions, thereby generating a second patient specific feedback; and providing the first and second specific feedbacks to the patient.

Abstract: Substance with pharmaceutical activity against a medical condition for use in a treatment of the medical condition in combination with a computer program product including instructions causing a computer to perform a method including the steps providing a patient with a set of questions (106) according to a question schedule, wherein the set of questions is adapted to the substance; providing a patient with a set of questions (126) according to a question schedule, wherein the set of questions is adapted to life style aspects of the medical condition; collecting answers to the sets of questions from the patient; subjecting the answers to the questions (106, 126) to a set of functions (108, 128), thereby generating specific feedback information; and providing the patient specific feedback to the patient.

Abstract: The present invention relates to a substance with pharmaceutical activity against a medical condition for use in a treatment of said medical condition in combination with a computer program product comprising instructions causing a computer to perform a method comprising the steps —providing a patient with a set of questions according to a question schedule, wherein said set of questions is specific to the pharmaceutical product; —collecting answers to said questions from said patient; —subjecting said answers to a set of functions specific for the set of questions and the pharmaceutical product thereby generating patient-specific feedback information; —providing said feedback information to the patient; and —optionally extracting clinically relevant information from said answers and providing said clinically relevant information to a database adapted for collecting clinically relevant information during clinical use of said substance.

Abstract: A method and system of managing health related variables in a system for collecting data from one or more remote units to a central unit is disclosed. A set of health related variables is defined for which data should be collected from a remote unit associated with an individual and the set of health related variables is sent from the central unit to the remote unit.